CAP Emphasizes Crucial Role of Rapid POCT in Combating STIs, Driving Efficient Care

September 20, 2026

The National Law Review USA

Overview

The College of American Pathologists (CAP) has published an article highlighting the significant benefits of point-of-care testing (POCT) for sexually transmitted infections (STIs), emphasizing its role in streamlining diagnosis-to-treatment workflows. With FDA-authorized and CLIA-waived POCT options now available for major STIs like chlamydia and gonorrhea, single-visit testing, diagnosis, and immediate treatment are achievable. This rapid intervention reduces unnecessary antibiotic use and curtails infection transmission, profoundly impacting public health outcomes.

In Depth

Key Findings

The College of American Pathologists (CAP) has released an article strongly advocating for the expanded adoption of point-of-care testing (POCT) for sexually transmitted infections (STIs), asserting its critical role in enhancing healthcare efficiency and mitigating infection spread. The availability of FDA-authorized and CLIA-waived POCT options for key STIs, including chlamydia and gonorrhea, now enables comprehensive testing, diagnosis, and treatment within a single patient visit, significantly reducing delays and improving patient outcomes.

Technical / Clinical Details

Target STIs and Technology: POCT is now accessible for common bacterial STIs such as Chlamydia trachomatis and Neisseria gonorrhoeae, with ongoing advancements for viral STIs. These assays offer diagnostic accuracy comparable to traditional lab-based methods but deliver results rapidly, often within minutes.
Regulatory Clearances: Several new POCT devices have received FDA authorization and CLIA-waived status. CLIA-waived tests are characterized by their simplicity and low risk of erroneous results, permitting their use by non-laboratory personnel in diverse clinical settings, including primary care offices, urgent care centers, and mobile clinics. This regulatory status is pivotal for broad implementation.
Efficiency in Care Delivery: The primary advantage of STI POCT is the capability to provide immediate test results, allowing clinicians to initiate treatment during the same patient encounter. This ‘test-and-treat’ model minimizes patient anxiety, reduces the need for follow-up appointments, and crucially, shortens the window for potential transmission to partners.

Background & Context

STIs remain a persistent global public health challenge, with delayed diagnosis and treatment contributing significantly to their spread and the development of severe complications like infertility and chronic pelvic pain. Conventional laboratory testing typically involves a waiting period of several days for results, during which patients may not return for treatment or may unknowingly transmit the infection. POCT directly addresses these logistical and public health challenges by bringing diagnostic capabilities closer to the patient.

Strategic Significance & Outlook

CAP views the widespread implementation of STI POCT as a transformative step in public health. Beyond controlling the spread of infections, rapid diagnosis and immediate treatment are expected to reduce the incidence of inappropriate antibiotic prescriptions, thereby helping to combat the growing threat of antimicrobial resistance. As more POCTs for various STIs become available, their integration into routine clinical practice will further enhance public health outcomes. Healthcare providers are urged to ensure adequate training and resources for effective POCT utilization to maximize these benefits.

Source: https://www.mlo-online.com/diagnostics/poct/news/55406195/cap-article-emphasizes-the-impact-of-point-of-care-testing-for-sexually-transmitted-infections

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.